Cardizem is a Oral Capsule, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Direct_rx. The primary component is Diltiazem Hydrochloride.
Product ID | 72189-409_f1ea85b2-ecd3-5867-e053-2a95a90a24dc |
NDC | 72189-409 |
Product Type | Human Prescription Drug |
Proprietary Name | Cardizem |
Generic Name | Diltiazem Hcl Er |
Dosage Form | Capsule, Extended Release |
Route of Administration | ORAL |
Marketing Start Date | 2023-01-10 |
Marketing Category | ANDA / |
Application Number | ANDA208783 |
Labeler Name | Direct_Rx |
Substance Name | DILTIAZEM HYDROCHLORIDE |
Active Ingredient Strength | 300 mg/1 |
Pharm Classes | Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2024-12-31 |
Marketing Start Date | 2023-01-10 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0187-0771 | Cardizem | Diltiazem Hydrochloride |
0187-0772 | Cardizem | Diltiazem Hydrochloride |
0187-0792 | Cardizem | Diltiazem Hydrochloride |
72189-409 | Cardizem | Diltiazem HCL ER |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
CARDIZEM 73633651 1444842 Live/Registered |
MARION LABORATORIES, INC. 1986-12-04 |
CARDIZEM 73293970 1246194 Live/Registered |
Marion Laboratories, Inc. 1981-01-22 |